Michael R. Zalutsky, Ph.D., is the Jonathan Spicehandler, M.D., Professor of Neuro-Oncology Research and a Professor in the Departments of Radiology, Radiation Oncology, Pathology and Biomedical Engineering at Duke University. 

Dr. Blackwell is the co-founder of Cereius and the Vice President, Early Phase Development at Eli Lilly and Company. She is a board certified medical oncologist, having trained at Mayo Clinic Medical School and Duke University Medical Center.

Ed Field has 20+ years c-level experience in building and selling numerous early-stage and publicly-traded biotechnology companies.

Jeffrey L. Schaal, Ph.D.

Director of research

Jeff is an expert in recombinant engineering of peptide/protein sequences, nanoparticle design for drug delivery systems, creating and extensive testing animal models of cancer, and developing next-generation radionuclide therapeutics for overcoming tumor resistance to conventional radio chemotherapy.

Scientific Advisory Board

Tona Gilmer Ph.D

Martin Pomper MD, Ph.D

Martin Pegram MD

Neil Spector MD

 

Join the Cereius Team

Click on the link below to view open positions in the company.